The Biolympix team boasts decades of industrial bioprocessing and academic biotechnology, experience from leading biopharmaceutical companies. Our expertise spans biological drug development, CMC activities, tech transfers, manufacturing facility establishment, business development, contract manufacturing organization (CMO) services, mRNA and gene-editing technologies, process development, viral vector production, and cell and gene therapy processes.
The Biolympix team boasts decades of industrial bioprocessing and academic biotechnology experience from leading biopharmaceutical companies. Our expertise spans biological drug development, CMC activities, tech transfers, manufacturing facility establishment, business development, contract manufacturing organization (CMO) services, mRNA and gene-editing technologies, process development, viral vector production, and cell and gene therapy processes.
We offer consultation services in the following areas:
We also specialize in talent development and staff training within manufacturing and development settings, including:
Join us for a rich and interactive biotech course, where your staff and scientists will learn new biotech applications, strengthen their experience and cross pollinate new business ideas for your company or institute to better serve the biotech sector
The participant be taught by world leaders in industrial biotech, and will gain an immersive experience in learning about current market trends, biologics therapeutics applications, and how to hit the ground running as a biotechnologist
The participant will be immersed in a real life example of an advanced drug development case study, where the participant will learn how to gather funding for a new biotech startup, learn the different clinical phases of drug development, navigate the various regulatory challenges and craft a clinical supply strategy
Our consulting service for IND-enabling biologics provides comprehensive support to navigate the complex regulatory landscape. We assist in the preparation and submission of Investigational New Drug (IND) applications, ensuring compliance with regulatory requirements. Our team of experts offers strategic guidance on CMC documentation, accelerating your biologics' path from development to clinical trials. With our extensive industry experience, we help you mitigate risks, streamline processes, and achieve successful IND submissions efficiently.